title: Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion.
abstract: A perifusion technique for microscopy with computerized detection of early changes in cell morphology during continuous perifusion was used to show that the geometry of cultured glioma cells (MG-251) changes rapidly when they are exposed to estramustine phosphate (EMP). When the cells were exposed to 20 or 40 mg l(-1) EMP, cell volume projected cell area (PCA) rapidly increased. When the Na+,K+-ATPase blocker ouabain (100 micromol l(-1)) was added to the EMP (40 mg l(-1)) perifusion, the acute EMP response was eradicated. When the PCA curve for ouabain alone was subtracted from the curve of combined ouabain and EMP perifusion, the resulting curve showed that ouabain completely blocked the EMP-induced increase in PCA. When the Na+, K+, Cl- co-transport inhibitors bumetanide (10 micromol l(-1)), or furosemide (100 micromol l(-1)), were added to EMP (40 mg l(-1)), the acute increase in PCA seen for EMP alone was also completely blocked. This study shows that inhibitors of ion transmembrane transport can modify EMP-induced cell volume increases. This may be of particular importance since the blockers have been found to interfere also with the cytotoxic function of EMP during cell culture. Thus, it is possible that cell volume changes could serve as a rapid technique for predicting the cytotoxic activity of antineoplastic drugs.
authors.affiliation: Department of Clinical Chemistry, Umeå University, Sweden.
authors.forename: P
authors.initials: P
authors.lastname: Behnam-Motlagh
authors.forename: O
authors.initials: O
authors.lastname: Jonsson
authors.forename: K G
authors.initials: KG
authors.lastname: Engström
authors.forename: R
authors.initials: R
authors.lastname: Henriksson
authors.forename: K
authors.initials: K
authors.lastname: Grankvist
mesh_terms: D002034:Bumetanide / Q000494:pharmacology; D048429:Cell Size / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004961:Estramustine / Q000494:pharmacology*; D005665:Furosemide / Q000494:pharmacology; D005910:Glioma / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D007473:Ion Channels / Q000187:drug effects*; D010042:Ouabain / Q000494:pharmacology; D010477:Perfusion; D014407:Tumor Cells, Cultured
chemical_list: D004791:Enzyme Inhibitors; D007473:Ion Channels; D002034:Bumetanide; D004961:Estramustine; D010042:Ouabain; D005665:Furosemide